Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 71,868 | 84,291 | 90,422 | 79,325 | 66,019 |
| Operating Income | -71,868 | -84,291 | -90,422 | -79,325 | -66,019 |
| Interest Expense | 1,980 | 2,006 | 1,996 | 1,986 | 1,978 |
| Other Income | 2,607 | 3,197 | 5,725 | 7,074 | 2,232 |
| Pre-tax Income | -71,241 | -83,100 | -86,693 | -74,237 | -65,765 |
| Income Tax | -311 | N/A | N/A | -107 | 575 |
| Net Income Continuous | -70,930 | -83,100 | -86,693 | -74,130 | -66,340 |
| Net Income | $-70,930 | $-83,100 | $-86,693 | $-74,130 | $-66,340 |
| EPS Basic Total Ops | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| EPS Basic Continuous Ops | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| EPS Diluted Total Ops | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| EPS Diluted Continuous Ops | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| EPS Diluted Before Non-Recurring Items | -0.77 | -0.90 | -0.95 | -0.82 | -0.79 |
| EBITDA(a) | $-71,154 | $-84,208 | $-90,888 | $-80,416 | $-66,819 |